Luliconazole dosage and administration

Revision as of 15:23, 8 January 2014 by Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Luliconazole}} {{CMG}}; {{AE}} {{AZ}} ==Dosage and Administration== For topical use only. LUZU Cream, 1% is not for ophthalmic, oral, or intravaginal use. When ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Luliconazole
LUZU® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Adverse Reactions
Drug Interactions
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage and Administration

For topical use only. LUZU Cream, 1% is not for ophthalmic, oral, or intravaginal use.

When treating interdigital tinea pedis, a thin layer of LUZU Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for two (2) weeks. When treating tinea cruris or tinea corporis, LUZU Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for one (1) week.[1]

References

  1. "LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.]".

Adapted from the FDA Package Insert.